Perspectives on percutaneous penetration: Silica nanoparticles

References

• Alikhan FS, Maibach HI. 2011. Topical absorption and systemic toxicity. Cutan Ocul Toxicol 30:175–86
   PubMed Web of Science ®Google Scholar
• Alnasif N, Zoschke C, Fleige E, Brodwolf R, Boreham A, Rühl E, et al. 2014. Penetration of normal, damaged and diseased skin – an in vitro study on dendritic core-multishell nanotransporters. J Control Release 185C:45–50
   Google Scholar
• Ambrogi V, Latterini L, Marmottini F, Pagano C, Ricci M. 2013. Mesoporous silicate MCM-41 as a particulate carrier for octyl methoxycinnamate: sunscreen release and photostability. J Pharm Sci 102:1468–75
   Web of Science ®Google Scholar
• Barbe C, Bartlett J, Kong LG, Finnie K, Lin HQ, Larkin M. 2004. Silica particles: a novel drug-delivery system. Adv Mater 16:1959–66
   Web of Science ®Google Scholar
• Bätz F, Klipper W, Korting HC, Henkler F, Landsiedel R, Luch A, et al. 2013. Esterase activity in excised and reconstructed human skin – biotransformation of prednicarbate and the model dye fluorescein diacetate. Eur J Pharm Biopharm 84:374–85
   PubMed Web of Science ®Google Scholar
• Benezra M, Penate-Medina O, Zanzonico P.B, Schaer D, Ow H, Burns A, et al. 2011. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest 121:2768–80
   PubMed Web of Science ®Google Scholar
• Berlier G, Gastaldi L, Ugazio E, Miletto I, Iliade P, Sapino S. 2013a. Stabilization of quercetin flavonoid in MCM-41 mesoporous silica: positive effect of surface functionalization. J Colloid Interface Sci 393:109–18
   PubMed Web of Science ®Google Scholar
• Berlier G, Gastaldi L, Sapino S, Miletto I, Bottinelli E, Chirio D, et al. 2013b. MCM-41 as a useful vector for rutin topical formulations: synthesis, characterization and testing. Int J Pharm 457:177–86
   PubMed Web of Science ®Google Scholar
• Bernstein IA, Vaughan FL. 1999. Cultured keratinocytes in in vitro dermatotoxicological investigation: a review. J Toxicol Environ Health B 2:1–30
   PubMed Web of Science ®Google Scholar
• Bharali DJ, Klejbor I, Stachowiak EK, Dutta P, Roy I, Kaur N, et al. 2005. Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. Proc Natl Acad Sci USA 102:11539–44
   PubMed Web of Science ®Google Scholar
• Boonen J, Baert B, Lambert J, De Spiegeleer B. 2011. Skin penetration of silica microparticles. Pharmazie 66:463–4
   Google Scholar
• Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, Ponec M. 2003. Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 42:1–36
   PubMed Web of Science ®Google Scholar
• Butz T. 2009. Dermal penetration of nanoparticles – What we know and what we don’t. SöFW J10 135:30–4
   Google Scholar
• Chen Y, Chen H, Shi J. 2013. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles. Adv Mater 18:3144–76
   Google Scholar
• Choi M, Cho WS, Han BS, Cho M, Kim SY, Yi JY, et al. 2008. Transient pulmonary fibrogenic effect induced by intratracheal instillation of ultrafine amorphous silica in A/J mice. Toxicol Lett 182:97–101
   PubMed Web of Science ®Google Scholar
• Choi HS, Liu W, Liu F, Nasr K, Misra P, Bawendi M.G, et al. 2010. Design considerations for tumor-targeted nanoparticles. Nat Nanotechnol 5:42–7
   PubMed Web of Science ®Google Scholar
• Crosera M, Bovenzi M, Maina G, Adami G, Zanette C, Florio C, et al. 2009. Nanoparticle dermal absorption and toxicity: a review of the literature. Int Arch Occup Environ Health 82:1043–55
   PubMed Web of Science ®Google Scholar
• De Louise LA. 2012. Applications of nanotechnology in dermatology. J Invest Dermatol 132:964–75
   Google Scholar
• De Villiers MM, Aramwit P, Kwon GS. 2009. Nanotechnology in Drug Delivery. Springer: AAPS Press
   Google Scholar
• Do N, Weindl G, Grohmann L, Salwiczek M, Koksch B, Korting HC, et al. 2014. Cationic membrane-active peptides – anticancer and antifungal activity as well as penetration into human skin. Exp Dermatol 23:326–31
   Google Scholar
• ECETOC. 2006. Synthetic amorphous silica (CAS No. 7631-86-9) – JACC REPORT No. 51. European Centre for Ecotoxicology and Toxicology of Chemicals, Brussels ISSN-0773-6339-51
   Google Scholar
• Elias Z, Poirot O, Daniere M.C, Terzetti F, Marande AM, Dzwigaj S, et al. 2000. Cytotoxic and transforming effects of silica particles with different surface properties in Syrian hamster embryo (SHE) cells. Toxicol In Vitro 14:409–22
   PubMed Web of Science ®Google Scholar
• Escobar-Chávez JJ, Merino-Sanjuan V, Lopez-Cervantes M, Urban-Morlan Z, Pinon-Segundo E, Quintanar-Guerrero D, et al. 2008. The tape stripping technique as a method for drug qualification in skin. J Pharm Pharm Sci 11:104–30
   PubMed Web of Science ®Google Scholar
• EU Commission Recommendation. 2011. Definition of nanomaterial. Available at: http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:275:0038:0040:EN:PDF
   Google Scholar
• Fenoglio I, Martra G, Coluccia S, Fubini B. 2000. Possible role of ascorbic acid in the oxidative damage induced by inhaled crystalline silica particles. Chem Res Toxicol 13:971–5
   PubMed Web of Science ®Google Scholar
• Franz J. 1975. Percutaneous absorption on the relevance of in-vitro data. J Invest Dermatol 67:190–5
   Google Scholar
• Friedman R. 2011. Nano dot technology enters clinical trials. J Natl Cancer Inst 103:1428–9
   PubMedGoogle Scholar
• Fruijtier-Pölloth C. 2012. The toxicological mode of action and the safety of synthetic amorphous silica-A nanostructured material. Toxicology 294:61–79
   PubMed Web of Science ®Google Scholar
• Gamer AO, Leibold E, van Ravenzwaay B. 2006. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol In Vitro 20:301–7
   PubMed Web of Science ®Google Scholar
• Garcia-Bennett AE. 2011. Synthesis, toxicology and potential of ordered mesoporous materials in nanomedicine. Nanomedicine 6:867–77
   Google Scholar
• Gastaldi L, Ugazio E, Sapino S, Iliade P, Miletto I, Berlier G. 2012. Mesoporous silica as a carrier for topical application: the Trolox case study. Phys Chem Chem Phys 14:11318–26
   Google Scholar
• Georgia State University. Hyperphysics. Abundances of the elements in the earth's crust. Available at: http://hyperphysics.phy-astr.gsu.edu/hbase/tables/elabund.html
   Google Scholar
• Ghouchi-Eskandar N, Simovic S, Prestidge CA. 2009a. Chemical stability and phase distribution of all-trans-retinol in nanoparticle-coated emulsions. Int J Pharm 376:186–94
   Google Scholar
• Ghouchi-Eskandar N, Simovic S, Prestidge CA. 2009b. Nanoparticle coated emulsions as novel dermal delivery vehicles. Curr Drug Deliv 6:367–73
   Google Scholar
• Ghouchi-Eskandar N, Simovic S, Prestidge CA. 2012. Solid-state nanoparticle coated emulsions for encapsulation and improving the chemical stability of all-trans-retinol. Int J Pharm 423:384–91
   PubMed Web of Science ®Google Scholar
• Götz C, Pfeiffer R, Tigges J, Blatz V, Jäckh C, Freytag EM, et al. 2012. Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I). Exp Dermatol 1:358–63
   Google Scholar
• Guth K, Riviere JE, Brooks JD, Dammann M, Fabian E, van Ravenzwaay B, et al. 2014. In silico models to predict dermal absorption from complex agrochemical formulations. SAR QSAR Environ Res 25:565–88
   Google Scholar
• Hayes AW, Kruger CL. 2014. Hayes' Principles and Methods of Toxicology. New York: CRC Press
   Google Scholar
• Hoffmann F, Cornelius M, Morell J, Fröba M. 2006. Silica-based mesoporous organic-inorganic hybrid materials. Angew Chem Int Ed 45:3216–51
   PubMed Web of Science ®Google Scholar
• Higaki K, Nakayama K, Suyama T, Amnuaikit C, Ogawara K, Kimura T. 2005. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin. Int J Pharm 288:227–33
   PubMed Web of Science ®Google Scholar
• Hirai T, Yoshikawa T, Nabeshi H, Yoshida T, Tochigi S, Ichihashi K, et al. 2012. Amorphous silica nanoparticles size-dependently aggravate atopic dermatitis-like skin lesions following an intradermal injection. Part Fibre Toxicol 9:3–14
   PubMed Web of Science ®Google Scholar
• Hudson SP, Padera RF, Langer R, Kohane DS. 2008. The biocompatibility of mesoporous silicates. Biomaterials 29:4045–55
   PubMed Web of Science ®Google Scholar
• IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 1997. Silica, some silicates, coal dust and para-aramid fibrils 68:1–475
   Google Scholar
• Iier RK. 1979. The Chemistry of Silica. New York: John Wiley & Sons
   Google Scholar
• IMA Europe. 2014. Crystalline silica and health from a European industry perspective. Available at: www.crystallinesilica.eu
   Google Scholar
• Jacobi U, Engel K, Patzelt A, Worm M, Sterry W, Lademann J. 2007. Penetration of pollen proteins into the skin. Skin Pharmacol Physiol 20:297–304
   Google Scholar
• Jäckh C, Blatz V, Fabian E, Guth K, van Ravenzwaay B, Reisinger K, et al. 2011. Characterization of enzyme activities of Cytochrome P450 enzymes, Flavin-dependent monooxygenases, N-acetyltransferases and UDP-glucuronyltransferases in human reconstructed epidermis and full-thickness skin models. Toxicol In Vitro 25:1209–14
   PubMed Web of Science ®Google Scholar
• Korting HC, Schäfer-Korting M. 2010. Carriers in the topical treatment of skin disease. Handb Exp Pharmacol 197:435–68
   PubMedGoogle Scholar
• Kresge CT, Leonowicz ME, Roth WJ, Vartul JC, Beck JS. 1992. Ordered mesoporous molecular sieves synthesized by a liquid–crystal template mechanism. Nature 359:710–12
   Web of Science ®Google Scholar
• Kreyling WG, Behnke MS, Chaudhry Q. 2010. A complementary, definition of nanomaterial. Nano Today 5:165–8
   Web of Science ®Google Scholar
• Labouta HI, Schneider M. 2013. Interaction of inorganic nanoparticles with the skin barrier: current status and critical review. Nanomed: Nanotechnol Biol Med 9:39–54
   PubMed Web of Science ®Google Scholar
• Lademann J, Patzelt A, Richter H, Antoniou C, Sterry W, Knorr F. 2009. Determination of the cuticula thickness of human and porcine hairs and their potential influence on the penetration of nanoparticles into the hair follicles. J Biomed Opt 14:021014-1–4
   Google Scholar
• Lademann J, Richter H, Schaefer UF, Blume-Peytavi U, Teichmann A, Otberg N, et al. 2006. Hair follicles – a long-term reservoir for drug delivery. Skin Pharmacol Physiol 19:232–6
   PubMed Web of Science ®Google Scholar
• Leach DR, Krummel MF, Allison J.P. 1996. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734–6
   PubMed Web of Science ®Google Scholar
• Lee CH, Cheng SH, Wang YJ, Chen YC, Chen NT, Souris J, et al. 2009. Near-infrared mesoporous silica nanoparticles for optical imaging: characterization and in vivo biodistribution. Adv Funct Mater 19:215–22
   Web of Science ®Google Scholar
• Lei C, Liu P, Chen B, Mao Y, Engelmann H, Shin Y, et al. 2010. Local release of highly loaded antibodies from functionalized nanoporous support for cancer immunotherapy. J Am Chem Soc 132:6906–7
   PubMed Web of Science ®Google Scholar
• Liu J, Qiao SZ, Chen JS, Lou XWD, Xing X, Lu GQM. 2011. Yolk/shell nanoparticles: new platforms for nanoreactors, drug delivery and lithium-ion batteries. Chem Commun 47:12578–91
   PubMed Web of Science ®Google Scholar
• Lou XWD, Archer LA, Yang Z. 2008. Hollow micro-/nanostructures: synthesis and applications. Adv Mater 20:3987–4019
   Web of Science ®Google Scholar
• Low SP, Voelcker NH, Canham LT, Williams KA. 2009. The biocompatibility of porous silicon in tissues of the eye. Biomaterials 30:2873–80
   PubMed Web of Science ®Google Scholar
• Mangelsdorf S, Otberg N, Maibach HI, Sinkgraven R, Sterry W, Lademann J. 2006. Ethnic variation in vellus hair follicle size and distribution. Skin Pharmacol Physiol 19:159–67
   Google Scholar
• Marzulli F.N, Maibach H.I. 1975. Relevance of animal models – the hexachlorophene story. In Maibach HI, ed. Animal Models in Dermatology. Edinburgh: Churchill Living Stone, 156–67
   Google Scholar
• Mavon A, Miquel C, Lejeune O, Payre B, Moretto P. 2007. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacol Physiol 20:10–20
   PubMed Web of Science ®Google Scholar
• Meinke MC, Patzelt A, Richter H, Schanzer S, Sterry W, Filbry A, et al. 2011. Prevention of follicular penetration: barrier-enhancing formulations against the penetration of pollen allergens into hair follicles. Skin Pharmacol Physiol 24:144–50
   PubMed Web of Science ®Google Scholar
• Menczel E, Maibach HI. 1970. In vitro human percutaneous penetration of benzyl alcohol and testosterone: epidermal–dermal retention. J Invest Dermatol 54:386–94
   PubMed Web of Science ®Google Scholar
• Michel K, Scheel J, Karsten S, Stelter N, Wind T. 2013. Risk assessment of amorphous silicon dioxide nanoparticles in a glass cleaner formulation. Nanotoxicology 7:974–88
   PubMed Web of Science ®Google Scholar
• Moger J, Johnston BD, Tyler CR. 2008. Imaging metal oxide nanoparticles in biological structures with CARS microscopy. Opt Express 16:3408–19
   PubMed Web of Science ®Google Scholar
• Monteiro-Riviere NA, Inman AO. 2006. Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 44:1070–8
   Web of Science ®Google Scholar
• Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Tochigi S, Kondoh S, et al. 2011a. Amorphous nanosilica induce endocytosis dependent ROS generation and DNA damage in human keratinocytes. Part Fibre Toxicol 8:1–10
   PubMed Web of Science ®Google Scholar
• Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Matsuo K, Arimori A, et al. 2011b. Systemic distribution, nuclear entry and cytotoxicity of amorphous nanosilica following topical application. Biomaterials 32:2713–24
   PubMed Web of Science ®Google Scholar
• Napierska D, Thomassen LC, Lison D, Martens JA, Hoet PH. 2010. The nanosilica hazard: another variable entity. Part Fibre Toxicol 7:39–71
   PubMed Web of Science ®Google Scholar
• Nel A, Xia T, Meng H, Wang X, Lin S, Ji Z, Zhang H. 2013. Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. Acc Chem Res 46:607–21
   PubMed Web of Science ®Google Scholar
• Ngo MA, Malley MO, Maibach HI. 2010. Percutaneous absorption and exposure assessment of pesticides. J Appl Toxicol 30:91–114
   PubMed Web of Science ®Google Scholar
• Ngo MA, Malley MO, Maibach HI. 2012. Perspectives on percutaneous penetration of nanomaterials. In Nasir A, Friedman A, Wang S, eds. Nanotechnology in Dermatology. New York: Springer, 63–86
   Google Scholar
• Nigg H.N, Stamper JH. 1989. Biological monitoring for pesticide dose determination. In Wang RGM, Franklin CA, Honeycutt RC, Reinert JC, eds. Biological Monitoring for Pesticide Exposure: Measurement, Estimation, and Risk Reduction. Washington DC: American Chemical Society, 6–27
   Google Scholar
• Nohynek GJ, Lademann J, Ribaud C, Roberts MS. 2007. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit Rev Toxicol 37:251–77
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, et al. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8
   PubMed Web of Science ®Google Scholar
• OECD SIDS. 2004. Synthetic amorphous silica and silicates. Available at: http://www.chem.unep.ch/irptc/sids/oecdsids/Silicates.pdf
   Google Scholar
• OSHA 3177. Occupational Safety and Health Administration. 2002. Crystalline silica exposure. Health hazard information for construction employees. Available at: https://www.osha.gov/Publications/osha3177.pdf
   Google Scholar
• Ostrowski A, Nordmeyer D, Boreham A, Brodwolf R, Mundhenk L, Fluhr JW. in press. Skin barrier disruptions in tape stripped and allergic dermatitis models have no effect on dermal penetration and systemic distribution of AHAPS-functionalized silica nanoparticles. Nanomedicine
   Google Scholar
• Otberg N, Patzelt A, Rasulev U, Hagemeister T, Linscheid M, Sinkgraven R, et al. 2008. The role of hair follicles in the percutaneous absorption of caffeine. Br J Clin Pharmacol 65:488–92
   PubMed Web of Science ®Google Scholar
• Otterstedt JE, Brandreth DA. 1998. Small Particles Technology. New York: Plenum Press
   Google Scholar
• Park YH, Bae HC, Jang Y, Jeong SH, Lee HN, Ryu WI, et al. 2013. Effect of the size and surface charge of silica nanoparticles on cutaneous toxicity. Mol Cell Toxicol 9:67–74
   Web of Science ®Google Scholar
• Park YH, Kim JN, Jeong SH, Choi JE, Lee SH, Choi BH, et al. 2010. Assessment of dermal toxicity of nanosilica using cultured keratinocytes, a human skin equivalent model and an in vivo model. Toxicology 267:178–81
   PubMed Web of Science ®Google Scholar
• Patzelt A, Richter H, Knorr F, Schafer U, Lehr CM, Dahne L, et al. 2011. Selective follicular targeting by modification of the particle sizes. J Control Release 150:45–8
   PubMed Web of Science ®Google Scholar
• Pfluecker F, Wendel V, Hohenberg H, Gartner E, Will T, Pfeiffer S, et al. 2001. The human stratum corneum layer: an effective barrier against dermal uptake of different forms of topically applied micronised titanium dioxide. Skin Pharmacol Appl Skin Physiol 14:92–7
   PubMedGoogle Scholar
• Piao Y, Burns A, Kim J, Wiesner U, Hyeon T. 2008. Designed fabrication of silica-based nanostructured particle systems for nanomedicine applications. Adv Funct Mater 18:3745–58
   Web of Science ®Google Scholar
• Pilloni M, Ennas G, Casu M, Fadda AM, Frongia F, Marongiu F, et al. 2013. Drug silica nanocomposite: preparation, characterization and skin permeation studies. Pharm Dev Technol 18:626–33
   PubMed Web of Science ®Google Scholar
• Poland CA, Read SAK, Varet J, Carse G, Christensen FM, Hankin SM. 2013. Dermal absorption of nanaomaterials. Environmental Project No. 1504. Denmark: The Danish Environmental Protection Agency
   Google Scholar
• Prausnitz MR, Elias PM, Franz TJ, Schmuth M, Tsai JC, Menon GK, et al. 2012. Skin barrier and transdermal drug delivery. In: Bolognia J, Jorizzo JL, Schaffer JV, eds. Dermatology. Philadelphia, PA: Elsevier Saunders, 2065–73
   Google Scholar
• Proksch E, Brandner JM, Jensen JM. 2008. The skin: an indispensable barrier. Exp Dermatol 17:1063–72
   PubMed Web of Science ®Google Scholar
• Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, et al. 2011. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 63:470–91
   PubMed Web of Science ®Google Scholar
• Quignard S, Mosser G, Boissière M, Coradin T. 2012. Long-term fate of silica nanoparticles interacting with human dermal fibroblasts. Biomaterials 33:4431–42
   Google Scholar
• Rancan F, Gao Q, Graf C, Troppens S, Hadam S, Hackbarth S, et al. 2012. Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization, and colloidal stability. ACS Nano 6:6829–42
   PubMed Web of Science ®Google Scholar
• Rosenholm JM, Sahlgren C, Linden M. 2011. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment. Curr Drug Targets 12:1166–86
   PubMed Web of Science ®Google Scholar
• Rougier A, Lotte C, Maibach HI. 1987. In vivo percutaneous penetration of some organic compounds related to anatomic site in humans: predictive assessment by the stripping method. J Pharm Sci 76:451–4
   PubMed Web of Science ®Google Scholar
• Scalia S, Franceschinis E, Bertelli D, Iannuccelli V. 2013. Comparative evaluation of the effect of permeation enhancers, lipid nanoparticles and colloidal silica on in vivo human skin penetration of quercetin. Skin Pharmacol Physiol 26:57–67
   Google Scholar
• SCCP – Scientific Committee on Consumer Products. 2007. Preliminary opinion on safety of nanomaterials in cosmetic products. Available at: http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_099.pdf
   Google Scholar
• Scheuplein RJ. 1967. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol 48:79–88
   PubMed Web of Science ®Google Scholar
• Schipper ML, Iyer G, Koh AL, Cheng Z, Ebenstein Y, Aharoni A, et al. 2009. Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small 5:126–34
   PubMed Web of Science ®Google Scholar
• Scodeller P, Catalano PN, Salguero N, Duran H, Wolosiuk A, Soler-Illia G.J.A.A. 2013. Hyaluronan degrading silica nanoparticles for skin cancer therapy. Nanoscale 5:9690–8
   Google Scholar
• Slowing II, Vivero-Escoto JL, Wu CW, Lin VSY. 2008. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60:1278–88
   PubMed Web of Science ®Google Scholar
• Slowing II, Vivero-Escoto JL, Trewyn BG, Lin VSY. 2010. Mesoporous silica nanoparticles: structural design and applications. J Mater Chem 20:7924–37
   Web of Science ®Google Scholar
• Smith EW, Maibach HI. 2006. Percutaneous Penetration Enhancers. Boca Raton: CRC Press
   Google Scholar
• Som C, Wick P, Krug H, Nowack B. 2011. Environmental and health effects of nanomaterials in nanotextiles and facade coatings. Environ Int 37:1131–42
   PubMed Web of Science ®Google Scholar
• Stöber W, Fink A. 1968. Controlled growth of monodisperse silica spheres in the micron size range. J Colloid Interface Sci 26:62–9
   Web of Science ®Google Scholar
• Takahashi H, Yoshioka Y, Hirai T, Ichihashi KI, Nishijima N, Yoshida T, et al. 2013. The size effects of amorphous silica nanoparticles on atopic dermatitis-like skin lesion (P6259). J Immunol 190:181.12
   Google Scholar
• Tang L, Cheng J. 2013. Nonporous silica nanoparticles for nanomedicine application. Nano Today 8:290–312
   PubMed Web of Science ®Google Scholar
• Tang F, Li L, Chen D. 2012. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater 24:1504–34
   PubMed Web of Science ®Google Scholar
• Thurn KT, Brown E, Wu A, Vogt S, Lai B, Maser J, et al. 2007. Nanoparticles for applications in cellular imaging. Nanoscale Res Lett 2:430–41
   PubMed Web of Science ®Google Scholar
• Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi U. 2004. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol 123:168–76
   PubMed Web of Science ®Google Scholar
• Tregear RT. 1966. Physical Functions of Skin. London: Academic Press
   Google Scholar
• Trommer H, Neubert RH. 2006. Overcoming the stratum corneum: the modulation of skin penetration. A review. Skin Pharmacol Physiol 19:106–21
   PubMed Web of Science ®Google Scholar
• Tsunoda S. 2011. Transdermal penetration and biodistribution of nanomaterials and their acute toxicity in vivo. Yakugaku Zasshi 131:203–7
   Google Scholar
• Unger KK. 1979. Porous Silica. Amsterdam, Oxford, New York: Elsevier
   Google Scholar
• Vallet-Regi M, Balas F, Arcos D. 2007. Mesoporous materials for drug delivery. Angew Chem, Int Ed 46:7548–58
   PubMed Web of Science ®Google Scholar
• Van Blaadern A, Van Geest J, Vrij A. 1992. Monodisperse colloidal silica spheres from tetraalkoxysilanes: particle formation and growth mechanism. J Colloid Interface Sci 154:481–501
   Google Scholar
• Vogt A, Combadiere B, Hadam S, Stieler KM, Lademann J, Schaefer H, et al. 2006. 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol 126:1316–22
   PubMed Web of Science ®Google Scholar
• Wan Y, Zhao DY. 2007. On the controllable soft-templating approach to mesoporous silicates. Chem Rev 107:2821–60
   PubMed Web of Science ®Google Scholar
• Waters KM, Masiello LM, Zangar RC, Tarasevich BJ, Karin NJ, Quesenberry RD, et al. 2009. Macrophage responses to silica nanoparticles are highly conserved across particle sizes. Toxicol Sci 107:553–69
   PubMed Web of Science ®Google Scholar
• Welsher K, Sherlock SP, Dai H. 2011. Deep-tissue anatomical imaging of mice using carbon nanotube fluorophores in the second near-infrared window. PNAS 108:8943–8
   PubMed Web of Science ®Google Scholar
• Wester RC, Noonan PK, Maibach HI. 1977. Frequency of application on percutaneous absorption of hydrocortisone. Arch Dermatol 113:620–2
   PubMed Web of Science ®Google Scholar
• Wester RC, Noonan PK, Maibach HI. 1980. Variations in percutaneous absorption of testosterone in the rhesusmonkey due to anatomic site of application and frequency of application. Arch Dermatol Res 267:229–35
   PubMed Web of Science ®Google Scholar
• Wilhelm KP, Zhai H, Maibach HI. 2012. Dermatotoxicology. New York: CRC Press
   Google Scholar
• Willey JD. 1982. Amorphous silica. Kirk-Othmer Encyclopedia of Chemical Technology, vol. 20. New York: John Wiley & Sons, 766–81
   Google Scholar
• Xia Y, Gates B, Yin Y, Lu Y. 2000. Monodispersed colloidal spheres: old materials with new applications. Colloidal spheres. Adv Mater 12:693–713
   Web of Science ®Google Scholar
• Yu T, Greish K, McGill LD, Ray A, Ghandehari H. 2012. Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold. ACS Nano 6:2289–301
   PubMed Web of Science ®Google Scholar
• Yu T, Malugin A, Ghandehari H. 2011. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 5:5717–28
   PubMed Web of Science ®Google Scholar
• Yu KO, Grabinski CM, Schrand AM, Murdock RC, Wang W, Gu B, et al. 2009. Toxicity of amorphous silica nanoparticles in mouse keratinocytes. J Nanopart Res 11:15–24
   Web of Science ®Google Scholar
• Zhang JH, Zhan P, Wang ZL, Zhang WY, Ming NB. 2003. Preparation of monodisperse silica particles with controllable size and shape. J Mater Res 18:649–53
   Web of Science ®Google Scholar
• Zhang YY, Hu L, Yu DH, Gao CY. 2010. Influence of silica particle internalization on adhesion and migration of human dermal fibroblasts. Biomaterials 31:8465–74
   Google Scholar